Screener
Relay Therapeutics, Inc. RLAY Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Relay Therapeutics, Inc.’s reported figures.
The source filing: Relay Therapeutics, Inc.’s 10-K, filed February 26, 2026. Open the filing →
- Filed
- Feb 25, 2026, 7:00 PM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-076739
FAQ
- What is Relay Therapeutics, Inc.'s free cash flow?
- Relay Therapeutics, Inc. (RLAY) reported free cash flow of -$44.87M in Q4 2025.
- How has Relay Therapeutics, Inc.'s free cash flow changed year-over-year?
- Relay Therapeutics, Inc.'s free cash flow increased by 22.5% year-over-year, from -$57.87M to -$44.87M.
- What is the long-term trend for Relay Therapeutics, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s free cash flow has grown at a 31.9% compound annual growth rate (CAGR), from -$77.88M to -$235.87M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Relay Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude